WUHAN EASY DIAGNOSIS BIOMEDICINE CO.,LTD.

Andere talen Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

Aandelen

002932

CNE1000033Q7

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 06-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
20,72 ^CNY	-0,34%		+1,47%	-9,80%

27/03	Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SZSE:002932) kondigt een aandeleninkoop aan voor CNY 350 miljoen aan aandelen.	CI
01/03	Wuhan Easy Diagnosis Biomedicine Co.,Ltd. keurt een terugkoopplan goed.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Proposes Final Cash Dividend for Year 2023	26/04
Tranche Update on Wuhan Easy Diagnosis Biomedicine Co.,Ltd.'s Equity Buyback Plan announced on March 28, 2024.	01/04
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. commences an Equity Buyback Plan for CNY 350 million worth of its shares, under the authorization approved on March 18, 2024.	27/03
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. authorizes a Buyback Plan.	01/03
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30-10-23
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	31-08-23
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 06 June 2023	30-05-23
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Approves Dividend for 2022	15-05-23
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26-04-23
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Proposes Profit Distribution for 2022	21-04-23
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	20-04-23
China stocks retreat on concerns of surging COVID cases	12-12-22
China stocks retreat on concerns of rising COVID cases	12-12-22
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26-10-22
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Announces Executive Elections	24-10-22
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.(XSEC:002932) added to S&P Global BMI Index	19-09-22
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Announces Interim Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 21 September 2022	14-09-22
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Approves Interim Cash Dividend for 2022	13-09-22
Zhuhai Digifluidic Biotechnology Co., Ltd. announced that it has received CNY 100.596565 million in funding from Wuhan Easy Diagnosis Biomedicine Co.,Ltd., Guangzhou Funway Asset Management Co., Ltd., Guangzhou Huiju Xinxing Equity Investment Partnership	13-09-22
Zhuhai Digifluidic Biotechnology Co. announced that it expects to receive CNY 0.747 million in funding from Wuhan Easy Diagnosis Biomedicine Co.,Ltd., Guangzhou Funway Asset Management Co., Ltd., Guangzhou Huiju Xinxing Equity Investment Partnership and another investor	09-09-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

Aandelen

002932

CNE1000033Q7

Andere talen

Filters